Get the Stockscreener App
10.38
5.05%
-0.525
Corbus Pharmaceuticals Holdings Inc stock is traded at $10.38, with a volume of 562.36K.
It is down -5.05% in the last 24 hours and down -28.72% over the past month.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
See More
Previous Close:
$10.90
Open:
$10.94
24h Volume:
562.36K
Relative Volume:
1.99
Market Cap:
$127.09M
Revenue:
$1.54M
Net Income/Loss:
$-38.70M
P/E Ratio:
-2.2216
EPS:
-4.67
Net Cash Flow:
$-36.86M
1W Performance:
-37.04%
1M Performance:
-28.72%
6M Performance:
+65.60%
1Y Performance:
-45.27%
1-Day Range:
$10.13
$11.23
1-Week Range:
$10.13
$12.88
52-Week Range:
$4.64
$20.77
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Name
Corbus Pharmaceuticals Holdings Inc
Sector
Industry
Phone
617-963-0103
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA
Compare CRBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
10.37 | 185.29M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
418.69 | 105.80B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
653.17 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
437.21 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
853.48 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.96 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Resumed | B. Riley Securities | Buy |
| Feb-28-25 | Initiated | William Blair | Outperform |
| Dec-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Initiated | Wedbush | Outperform |
| Jul-22-24 | Resumed | H.C. Wainwright | Buy |
| Jun-26-24 | Initiated | B. Riley Securities | Buy |
| Jun-03-24 | Reiterated | Oppenheimer | Outperform |
| May-13-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-06-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-08-20 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-08-20 | Downgrade | Jefferies | Buy → Hold |
| Sep-08-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-08-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-07-20 | Initiated | ROTH Capital | Buy |
| Jun-17-20 | Initiated | BTIG Research | Buy |
| Mar-26-20 | Initiated | Nomura | Buy |
| Apr-05-19 | Initiated | Jefferies | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jan-11-19 | Reiterated | Cantor Fitzgerald | Overweight |
| Dec-26-18 | Initiated | H.C. Wainwright | Buy |
| Dec-07-18 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-18 | Initiated | B. Riley FBR | Buy |
| Jan-19-18 | Initiated | Raymond James | Outperform |
| Dec-14-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-08-17 | Reiterated | Noble Financial | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Mar-30-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-15-16 | Reiterated | JMP Securities | Mkt Outperform |
| Nov-11-16 | Reiterated | Noble Financial | Buy |
View All
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
Published on: 2025-11-06 10:07:04 - fcp.pa.gov.br
Corbus Pharma (NASDAQ: CRBP) to present at Guggenheim, Jefferies, Evercore Nov–Dec - Stock Titan
What analyst consensus says on Corbus Pharmaceuticals Holdings Inc. stockInsider Buying & Verified Entry Point Detection - newser.com
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarPortfolio Value Summary & Daily Entry Point Alerts - newser.com
Published on: 2025-11-06 05:11:16 - fcp.pa.gov.br
Published on: 2025-11-06 03:42:07 - fcp.pa.gov.br
Will Corbus Pharmaceuticals Holdings Inc. stock beat EPS estimatesMarket Risk Report & Real-Time Chart Pattern Alerts - fcp.pa.gov.br
Comparing Corbus Pharmaceuticals Holdings Inc. in custom built stock radarsBond Market & Short-Term Trading Opportunity Alerts - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock reach $100 price targetPortfolio Return Summary & Low Risk Investment Opportunities - newser.com
Corbus Pharmaceuticals: Data Update And Fundraising Efforts Do Not Diminish The Thesis - Seeking Alpha
Is Corbus Pharmaceuticals Holdings Inc a good long term investmentMomentum Stock Picks & Bull Bear Market Updates - earlytimes.in
Corbus Pharmaceuticals Announces Preliminary Q3 Financials - MSN
Published on: 2025-11-05 05:24:41 - newser.com
Corbus Pharmaceuticals Holdings Inc. Stock Falls 8.5%, Underperforms Peers - 富途牛牛
Published on: 2025-11-05 03:45:02 - newser.com
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidateQuarterly Profit Report & Real-Time Volume Analysis - newser.com
Understanding Corbus Pharmaceuticals Holdings Inc.’s price movementEntry Point & Daily Technical Forecast Reports - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock vulnerable to regulatory risksEntry Point & Safe Entry Momentum Stock Tips - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock sustain market leadershipPortfolio Update Summary & Real-Time Volume Analysis - newser.com
Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.2025 Market Sentiment & Fast Moving Market Watchlists - newser.com
Short interest data insights for Corbus Pharmaceuticals Holdings Inc.Market Growth Report & Fast Moving Stock Trade Plans - newser.com
Published on: 2025-11-04 00:52:02 - newser.com
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. lossesWeekly Trend Report & Verified Technical Trade Signals - newser.com
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.71 a shareEarnings Preview - TradingView
Corbus Pharmaceuticals Announces $70.5M Public Offering - TipRanks
Form 424B5 Corbus Pharmaceuticals - StreetInsider
Is Corbus Pharmaceuticals Holdings Inc. stock a contrarian buyPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Quantitative breakdown of Corbus Pharmaceuticals Holdings Inc. recent move2025 Top Gainers & High Yield Stock Recommendations - newser.com
Will breakout in Corbus Pharmaceuticals Holdings Inc. lead to full recoveryJuly 2025 Final Week & Pattern Based Trade Signal System - newser.com
AlphaQuest LLC Has $218,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat
How institutional buying supports Corbus Pharmaceuticals Holdings Inc. stockEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsWeekly Profit Analysis & Technical Buy Zone Confirmations - newser.com
How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockOil Prices & Growth Focused Stock Reports - newser.com
Corbus Pharmaceuticals slumps 17%, prices $75M at $13 per share - MSN
Published on: 2025-11-02 11:47:57 - newser.com
Published on: 2025-11-01 11:30:29 - newser.com
Published on: 2025-11-01 08:40:29 - newser.com
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cohen Yuval | Chief Executive Officer |
Oct 27 '25 |
Option Exercise |
4.26 |
8,973 |
38,225 |
147,160 |
| Cohen Yuval | Chief Executive Officer |
Oct 24 '25 |
Sale |
17.01 |
18,660 |
317,407 |
138,187 |
| Cohen Yuval | Chief Executive Officer |
Oct 27 '25 |
Sale |
17.14 |
8,973 |
153,797 |
138,187 |
| Moran Sean F. | Chief Financial Officer |
Oct 24 '25 |
Option Exercise |
4.26 |
12,981 |
55,299 |
86,294 |
| Moran Sean F. | Chief Financial Officer |
Oct 24 '25 |
Sale |
17.02 |
12,981 |
220,937 |
73,313 |
1.38%
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):